Literature DB >> 21910186

A review of acute stress disorder in DSM-5.

Richard A Bryant1, Matthew J Friedman, David Spiegel, Robert Ursano, James Strain.   

Abstract

Acute stress disorder (ASD) was introduced into DSM-IV to describe acute stress reactions (ASRs) that occur in the initial month after exposure to a traumatic event and before the possibility of diagnosing posttraumatic stress disorder (PTSD), and to identify trauma survivors in the acute phase who are high risk for PTSD. This review considers ASD in relation to other diagnostic approaches to acute stress responses, critiques the evidence of the predictive power of ASD, and discusses ASD in relation to Adjustment Disorder. The evidence suggests that ASD does not adequately identify most people who develop PTSD. This review presents a number of options and preliminary considerations to be considered for DSM-5. It is proposed that ASD be limited to describing severe ASRs (that are not necessarily precursors of PTSD). The evidence suggests that the current emphasis on dissociation may be overly restrictive and does not recognize the heterogeneity of early posttraumatic stress responses. It is proposed that ASD may be better conceptualized as the severity of acute stress responses that does not require specific clusters to be present.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21910186     DOI: 10.1002/da.20737

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  41 in total

1.  A First Step towards a Clinical Decision Support System for Post-traumatic Stress Disorders.

Authors:  Sisi Ma; Isaac R Galatzer-Levy; Xuya Wang; David Fenyö; Arieh Y Shalev
Journal:  AMIA Annu Symp Proc       Date:  2017-02-10

2.  Examining the Latent Structure of Acute Stress Disorder Symptoms in Filipino-Victims of a Flashflood Disaster.

Authors:  Imelu G Mordeno; Miriam P Cue
Journal:  Community Ment Health J       Date:  2015-01-10

3.  Traumatic Stress Disorders and Risk of Subsequent Schizophrenia Spectrum Disorder or Bipolar Disorder: A Nationwide Cohort Study.

Authors:  Niels Okkels; Betina Trabjerg; Mikkel Arendt; Carsten Bøcker Pedersen
Journal:  Schizophr Bull       Date:  2016-05-31       Impact factor: 9.306

Review 4.  Early Traumatic Stress Responses in Parents Following a Serious Illness in Their Child: A Systematic Review.

Authors:  Claudia Woolf; Frank Muscara; Vicki A Anderson; Maria C McCarthy
Journal:  J Clin Psychol Med Settings       Date:  2016-03

5.  Factors predicting risk for PTSD among highly exposed civilians: two longitudinal studies.

Authors:  Menachem Ben-Ezra; Yuval Palgi; Yaira Hamama-Raz; Amit Shrira
Journal:  Psychiatr Q       Date:  2015-03

Review 6.  The Current Evidence for Acute Stress Disorder.

Authors:  Richard A Bryant
Journal:  Curr Psychiatry Rep       Date:  2018-10-13       Impact factor: 5.285

7.  Towards trauma-informed legal practice: a review.

Authors:  Colin James
Journal:  Psychiatr Psychol Law       Date:  2020-02-11

8.  Self-medication among traumatized youth: structural equation modeling of pathways between trauma history, substance misuse, and psychological distress.

Authors:  Eric L Garland; Carrie Pettus-Davis; Matthew O Howard
Journal:  J Behav Med       Date:  2012-03-28

9.  Acute stress symptoms in children: results from an international data archive.

Authors:  Nancy Kassam-Adams; Patrick A Palmieri; Kristine Rork; Douglas L Delahanty; Justin Kenardy; Kristen L Kohser; Markus A Landolt; Robyne Le Brocque; Meghan L Marsac; Richard Meiser-Stedman; Reginald D V Nixon; Eric Bui; Caitlin McGrath
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2012-06-29       Impact factor: 8.829

10.  Predicting the Transition From Acute Stress Disorder to Posttraumatic Stress Disorder in Children With Severe Injuries.

Authors:  Ruth C Brown; Nicole R Nugent; Sage E Hawn; Karestan C Koenen; Alisa Miller; Ananda B Amstadter; Glenn Saxe
Journal:  J Pediatr Health Care       Date:  2016-01-14       Impact factor: 1.812

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.